- Set the global regulatory vision for pioneering cell therapies
- Own the end-to-end global regulatory strategy for high-complexity cell therapy programs
- Lead strategy for agency meetings, information requests, and expedited pathway designations
- Shape development and commercialization plans
- Oversee all regulatory deliverables and milestones
- Build strong relationships with regulatory stakeholders
- Lead a Global Regulatory Strategy Team for specific indications/programs
- Maintain accountability for product maintenance and compliance activities
Requirements
- An advanced degree in a science related field
- Seven to ten years of experience and/or appropriate knowledge/experience
- Demonstrated success in cell therapy regulatory strategy
- Deep understanding of global regulatory science and integration with program strategy
- Long standing experience of overall drug/biologic development processes
- Experience with product development in oncology, autoimmune, rare diseases, neurology
- Proven experience leading regulatory and cross-functional teams
- Excellent oral, written, and presentation skills
- Strong organizational skills
- Ability to work in a fast-paced environment
Core Competencies
Expertise in global regulatory strategy for cell therapies, with a strong focus on compliance, product development, and cross-functional team leadership. Proven ability to navigate complex regulatory environments and build relationships with stakeholders in the biotechnology sector.
Highest-signal resume keywords
- Cell Therapy Regulatory Strategy
- Global Regulatory Science
- Drug/Biologic Development Processes
- Regulatory Team Leadership
- Cross-Functional Collaboration
Hard Skills
- Regulatory Strategy Development
- Regulatory Deliverables Oversight
- Product Maintenance Compliance
- Agency Meeting Strategy
- Expedited Pathway Designation
Soft Skills
- Excellent Oral Communication
- Strong Organizational Skills
- Presentation Skills
Certifications & Qualifications
- Advanced Degree in Science
Industry Keywords
- Oncology
- Autoimmune Diseases
- Rare Diseases
- Neurology
- Regulatory Stakeholder Engagement
#J-18808-Ljbffr